Brussels, 28/10/2022 (Agence Europe) – On Tuesday 25 October, the European Medicines Agency (EMA) announced the publication of the clinical trial supporting the use of Comirnaty, the mRNA SARS-CoV-2 vaccine developed by the pharmaceutical companies Pfizer and BioNTech, as a booster dose for children aged 5 to 11 years. The EMA specifies that the publication of these clinical trials is done under the exceptional measures related to the Covid-19 epidemic. These exceptional measures were...